cancer vaccines
World Cancer Day 2026: What Cancer Vaccines Have Already Achieved in Real Clinical Practice (Cancer Vaccines — Part III) In the first two parts of this series, we explored the future of cancer vaccines through the lens of technology — from the rapid rise of mRNA platforms to the renewed momentum behind DNA-based approaches. But on World Cancer Day, innovation is best measured not by promise, but by impact. Read more
Clinical Research Focus. 49th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of February 2026. Read more
After JPM 2026: Where Healthcare Strategy Is Actually Heading By Vlad Bogin, MD, FACP CEO, Cromos Pharma The J.P. Morgan Healthcare Conference has always been a defining moment for the healthcare industry, not because of a single announcement, but because of the collective direction that emerges once the week is over. JPM 2026 followed that pattern, but with a noticeable shift in tone. This Read more
Clinical trial trends 2026
Clinical Research in 2026: What Changed — and Why It Matters  Key Takeaways   Clinical research is becoming more selective, not slower.  Capital, regulation, and policy volatility are forcing sharper prioritization and earlier decisions.  Execution quality now carries financial consequences.  Late-stage trials leave little room for operational error, weak endpoints, or slow enrollment.  Risk is moving upstream.  AI, alternative preclinical models, and modular global development are shifting decision-making earlier.  Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us